The <scp>OLGIMA</scp> system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus

The new OLGIMA system identifies patients at higher GC risk (OLGIMA III-IV), encompassing all OLGIM III-IV patients, and upstaging those OLGIM 0-II with advanced GA. This approach addresses the OLGA and OLGIM limitations by integrating GA and IM severity as recommended by the Updated Sydney consensus.

Authors

Institutions

Publication Details

Journal
Histopathology
Published
2025-11-26
DOI
https://doi.org/10.1111/his.70042
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus

Silvia Patricia Ortega, Míriam Cuatrecasas, Eva Barreiro Alonso, Glòria Fernández‐Esparrach et al.
Histopathology
Gastric Cancer Management and Outcomes
article

The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus

Silvia Patricia Ortega, Míriam Cuatrecasas, Eva Barreiro Alonso, Glòria Fernández‐Esparrach, Alberto Herreros de Tejada, Eduardo Albéniz, Diana Zaffalon, Carolina Mangas‐Sanjuán, Oliver Patrón, Sheyla Montori, Javier Tejedor‐Tejada, R. Carrillo Vicente, Leticia Moreira, Alaín Huerta, Gadea Hontoria, Henar Núñez, Linwah Yip, Pedro Delgado‐Guillena, Sara Zarraquiños, P Flórez-Díez, Iván Archilla, María José Domper-Arnal, Gonzalo Hijos, M Teresa Soria, Joan Llach, Luis Hernández, Nayra Felípez, Alicia Córdoba, Anabella Cuestas
article en

Abstract

The new OLGIMA system identifies patients at higher GC risk (OLGIMA III-IV), encompassing all OLGIM III-IV patients, and upstaging those OLGIM 0-II with advanced GA. This approach addresses the OLGA and OLGIM limitations by integrating GA and IM severity as recommended by the Updated Sydney consensus.

HistopathologyVol. 88(4)
University of the Basque Country (ES), Hospital Son Llatzer (ES), BioCruces Health research Institute (ES), Complejo Hospitalario de Navarra (ES), Consorci Sanitari de Terrassa (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Universitario Miguel Servet (ES), Hospital Clínic de Barcelona (ES), Hospital Universitario de Burgos (ES), Hospital de Galdakao (ES), Navarrabiomed (ES), Instituto de Arqueología-Mérida (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Centro de Implantología Cirugía Oral y Maxilofacial (ES), Hospital Universitari Sant Joan de Reus (ES), Hospital Universitario De Cabueñes (ES), Hospital Comarcal de Inca (ES), Hospital Universitario Río Hortega (ES), Fundació Clínic per a la Recerca Biomèdica (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Instituto de Investigación Sanitaria del Principado de Asturias (ES), Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (ES), Universidad de Burgos (ES), Universidad Autónoma de Madrid (ES), Universitat de Barcelona (ES), Universidad de Navarra (ES)
Openalex Percentile: Top 45%
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.